Celgene (CELG) Deal Is Likely To Close For 4 Reasons - Jefferies

February 28, 2019 9:30 AM EST Send to a Friend
Jefferies analyst, Michael Yee, reiterated his Hold rating on shares of Celgene (NASDAQ: CELG) after the top shareholder of BMY ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login